Profile
SYRA HCA THC FMS SOLV EHC
Company Name Syra Health Corp. Class A Common Stock HCA Healthcare, Inc. Tenet Healthcare Corporation Fresenius Medical Care AG & Co. KGaA Solventum Corporation Encompass Health Corporation
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Care Facilities Medical - Care Facilities Medical - Care Facilities Medical - Care Facilities Medical - Care Facilities Medical - Care Facilities
Market Cap $835.74K $96.73B $17.35B $14.27B $12.85B $12.69B
Employees 0.06K 226.00K 98.00K 112.04K 22.00K 28.57K
CEO Deepika Vuppalanchi Samuel N. Hazen Saumya Sutaria Helen Giza Bryan C. Hanson Mark J. Tarr
Ratings
SYRA HCA THC FMS SOLV EHC
Quant Rating Score 3 2 3 3 3 4
Quant Rating Neutral Sell Neutral Neutral Neutral Buy
Trading
SYRA HCA THC FMS SOLV EHC
Last Close $0.07 $399.75 $182.82 $25.34 $74.13 $123.81
High 52 $0.73 $420.77 $196.39 $29.85 $84.04 $126.8
Low 52 $0.06 $296.67 $110.41 $19.11 $63.01 $91.05
Price vs. 52 Week High -90.41 % -5 % -6.91 % -15.11 % -11.79 % -2.36 %
Price vs. 52 Week Low 16.67 % 34.75 % 65.58 % 32.6 % 17.65 % 35.98 %
Total Return
SYRA HCA THC FMS SOLV EHC
1 Month Return -11.05 % 1 % 6.28 % 1.04 % 3.79 % 2.85 %
3 Month Return -13.04 % 7.33 % 9.17 % -6.43 % 1.88 % 3.88 %
6 Month Return -79.74 % 21.7 % 42.83 % 4.75 % -1.36 % 26.66 %
9 Month Return -82.28 % 29.88 % 37.93 % 7.1 % 8.06 % 27.72 %
YTD Return -83.01 % 33.18 % 44.83 % 11.93 % 12.22 % 34.07 %
1 Year Return -83.53 % 0.57 % 16.48 % 21.36 % 2.49 % 35.58 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
SYRA HCA THC FMS SOLV EHC
Dividend Yield Percentage (TTM) - 0.67 % - 3.24 % - 0.54 %
Dividend Paid and Capex Coverage Ration (TTM) - 2.24 % 2.73 % 4.3 % 1.33 % 1.51 %
Dividend Per Share (TTM) - 2.76 % - 0.79 % - 0.68 %
Payout Ratio (TTM) - 11.47 % - - - 12.84 %
Growth
SYRA HCA THC FMS SOLV EHC
Asset Growth -25.27 % 5.87 % 2.2 % 0.56 % 7.08 %
Gross Profit Growth 17.35 % 9.56 % -30.04 % -2.13 % 164.83 %
Revenue Growth 44.73 % 8.67 % 0.57 % 0.7 % 11.91 %
Revenue 3 Year 467.5 % 50.24 % 16.92 % 0.59 % 3.97 %
Revenue 5 Year - 81.46 % 19.32 % 12.88 % 14.46 %
Revenue 10 Year - 210.95 % 25.53 % 12.88 % 96.63 %
EBIT Growth -29.78 % 9.75 % 141.22 % -41.69 % 18.16 %
Net Income Growth -27.94 % 9.88 % 423.73 % -64.41 % 29.46 %
Net Income 3 Yeari Growth Per Share -114790.66 % 3.53 % 138.85 % -67.33 % 9.56 %
Net Income 5 Yeari Growth Per Share -72364.33 % 116.83 % 2287.73 % -58.09 % 24.63 %
Net Income 10 Yeari Growth Per Share -72364.33 % 399.49 % 26813.51 % -58.09 % 78.35 %
Operating Income Growth -30.38 % 9.56 % 137.29 % -38.77 % 18.13 %
Operating Cash Flow Growth (CFG) -6.27 % 11.48 % -13.77 % -38.12 % 17.87 %
Operating 3 Year CFG -3232.45 % 46.72 % 43.92 % -46.41 % 38.83 %
Operating 5 Year CFG - 82.49 % 77.14 % -41.76 % 54.84 %
Operating 10 Year CFG - 284.34 % 200.72 % -41.76 % 95.84 %
EPS Growth 13.33 % 15.75 % 461.56 % -64.44 % 27.97 %
EPS Diluted Growth 13.33 % 16.03 % 472.68 % -64.57 % 28.53 %
Book Value Per Share -51.84 % -44.85 % 62.76 % -13.45 % 23.53 %
Share Holder 3 Year Equity Growth Per Share 40474.94 % -234.87 % 347.31 % -75.57 % 7.17 %
Share Holder 5 Year Equity Growth Per Share 56919.91 % -17.42 % 1299.6 % - 49.95 %
Share Holder 10 Year Equity Growth Per Share 56919.91 % 48.53 % 546.64 % - 217.08 %
Dividend Per Share Growth - 9.96 % - - 3.56 %
Dividend 3 Year Growth Per Share - 38.25 % - - -44.53 %
Dividend 5 Year Growth Per Share - 65.53 % - - -43.33 %
Dividend 10 Year Growth Per Share - 15927.31 % - - -24.32 %
Debt Growth 82.21 % 8.07 % -12.19 % 8073.47 % -7.47 %
Free Cash Flow Growth -6.09 % 20.31 % -31.24 % -50.46 % 34.59 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
SYRA HCA THC FMS SOLV EHC
Gross Profit Margin TTM 30.58 % 15.24 % 47.81 % 24.67 % 54.52 % 44.58 %
Return on Assets TTM -41.99 % 10.03 % 5.17 % 2.1 % 2.52 % 7.7 %
Return on Equity TTM -52.63 % -189.65 % 37.25 % 4.7 % 11.64 % 22.68 %
Return on Capital Employed TTM -60.77 % 25.41 % 15.17 % 5.77 % 6.24 % 16.34 %
Net Income Per EBT TTM 100 % 68 % 49.73 % 56.51 % 118.38 % 60.74 %
EBT Per Ebit TTM 99.37 % 79.27 % 80.54 % 78.59 % 41.31 % 88.95 %
EBIT Per Revenue TTM -18.19 % 15.24 % 17.91 % 7.57 % 9.26 % 17.07 %
Cash Flow To Debt Ratio TTM -498.05 % 25.74 % 18.71 % 24.99 % 7.5 % 302.52 %
Receivables Turnover TTM 9.1 6.95 5.59 6.04 7.88 9.26
Payables Turnover TTM 10.05 14.5 7.94 19.56 5.93 18
Inventory Turnover TTM - 34.39 31.94 7.37 3.97 -
Fixed Asset Turnover TTM 21953.1 % 225.22 % 343.43 % 300.35 % 638.84 % 140.47 %
Asset Turnover TTM 232.3 % 122.11 % 72.09 % 62.38 % 55.65 % 83.54 %
Operating Cash Flow Per Share TTM -0.05 49.34 27.05 4.69 3.37 10.99
Free Cash Flow Per Share TTM -0.05 30.14 17.15 3.96 0.84 4.37
Cash Per Share TTM 19.31 % 388.16 % 2880.34 % 373.2 % 282.6 % 98.51 %
Operating Cash Flow Sales Ratio TTM -6.72 % 16.42 % 11.92 % 14.11 % 6.99 % 19.5 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 61.1 % 63.41 % 84.45 % 25.09 % 39.73 %
Cash Flow Coverage Ratios TTM -498.05 % 25.74 % 18.71 % 24.99 % 7.5 % 302.52 %
Price To Free Cash Flows Ratio TTM -1.54 13.27 11.1 5.25 87.44 28.89
Price To Operating Cash Flows Ratio TTM -1.54 8.38 7.26 4.43 22.02 11.46
Price Cash Flow Ratio TTM -1.54 8.38 7.26 4.43 22.02 11.46
Income Statement (TTM)
SYRA HCA THC FMS SOLV EHC
Revenue $0.01B $70.6B $20.67B $19.34B $8.25B $5.37B
Gross Profit $0B $10.55B $8.21B $4.76B $4.59B $2.47B
Gross Profit Ratio 20.71% 14.94% 39.72% 24.6% 55.65% 46.01%
EBITDA $-0B $13.9B $6.89B $3.21B $1.53B $1.19B
Net Income $-0B $5.76B $3.2B $0.54B $0.48B $0.46B
EPS Diluted -0.52 22 32.7 0.92 2.76 4.46
Balance Sheet (MRQ)
SYRA HCA THC FMS SOLV EHC
Long Term Debt $0B $40.2B $13.08B $9.76B $7.9B $2.55B
Total Liabilities $0B $58.96B $20.39B $17.8B $11.5B $3.69B
Total Equity $0B $0.56B $8.55B $15.77B $2.96B $2.85B
Total Investments $0B $1.32B $1.81B $1.29B $0.02B $0.16B
Total Debt $0B $45.24B $13.17B $11B $8.01B $2.71B
Total Assets $0B $59.51B $28.94B $33.57B $14.46B $6.53B
Cash Flow Statement (TTM)
SYRA HCA THC FMS SOLV EHC
Net Income $-0B $6.66B $4.06B $0.74B $0.48B $0.6B
Inventory $0B $0.33B $0B $0.11B $-0.13B $0B
Dividends Paid $0B $-0.69B $0B $-0.35B $0B $-0.06B
Operating Cash Flow $-0B $10.51B $2.05B $2.39B $1.19B $1B
Capital Expenditure $-0B $-4.88B $-0.93B $-0.7B $-0.38B $-0.64B
Related Stocks
Ticker Name Price
ACHC Acadia Healthcare Company, Inc. 21.92
ADUS Addus HomeCare Corporation 107.98
AGL agilon health, inc. 1.14
AIH Aesthetic Medical International Holdings Group Limited 0.3334
AIRS AirSculpt Technologies, Inc. 6.185
ALR AlerisLife Inc. 1.32
AMED Amedisys, Inc. 100.99
AMEH Apollo Medical Holdings, Inc. 40.82
AMN AMN Healthcare Services, Inc. 19.015
AMS American Shared Hospital Services 2.53
AONC American Oncology Network, Inc. 10.75
ARDT Ardent Health Partners, LLC 12.84
ASTH Astrana Health, Inc. 29.04
ATIP ATI Physical Therapy, Inc. 0.675
AUNA 6.34
AVAH Aveanna Healthcare Holdings Inc. 8.085
BACK IMAC Holdings, Inc. 0.08
BKD Brookdale Senior Living Inc. 7.54
BKDT Brookdale Senior Living Inc. 7. 77.6
BTMD Haymaker Acquisition Corp. III 3.3395
ETFs With Exposure to SYRA
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 325.11
VXF Vanguard Extended Market Index Fund 0 209.23
VTSAX Vanguard Total Stock Market Index Fund 0 158.41
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 158.72
VITSX Vanguard Total Stock Market Index Fund 0 158.44
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 158.73
VEMPX Vanguard Extended Market Index InstlPlus 0 391.7
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 297.22
Unlock